The studies reviewed estimates of economic and humanistic impact on both patients with chronic kidney disease (CKD) as well as their caregivers.
A pair of posters presented at Kidney Week 2022 examined some of the burdens of people living with chronic kidney disease (CKD), as well as their caregivers.
The first study sought to review estimates of economic and humanistic impact among individuals with CKD in the United States.1
Using MEDLINE and Embase, researchers conducted a systematic review to identify studies reporting estimates of CKD economic or humanistic patient burden in the United States, published between 2016 and 2021. Study selection and data extraction were performed in duplicate, using PRISMA guidelines. A grey literature search was conducted for the past 5 years. Characteristics of patients with CKD, and estimates of economic and humanistic burden, were summarized.
From 4880 abstracts, 38 eligible studies were included.
Mean patient age ranged from 46.3 to 63.7 years; proportion of males ranged from 41.70% to 63.0%. Reported comorbidities included diabetes (23%.0-55.8%), cardiovascular disease (20.5%-63.0%), and hypertension (45.5%-97.0%).
Two studies reported out-of-pocket expenditures for patients with CKD, estimated at $1599 (mean) and $1807 (median) annually. More than 16% of patients had high OOP burden.
One study reported that 46.9% of patients with CKD of working age experienced financial hardship within the past year due to medical bills, with lack of health insurance being the strongest determinant; impacts included nonadherence to medication and delayed/foregone medical care.
Health-related quality of life (HRQOL) was assessed in 32 studies using a variety of instruments; high burden for patients with CKD was consistently demonstrated, with higher CKD stage linked with greater burden. Limited data were available on lost productivity.
The authors said the findings show the high economic and humanistic burden to individuals with CKD, although HRQOL data were heterogenous and economic data were limited.
The same authors conducted a second study, this time looking at the impact on unpaid caregivers.2 Using the same search strategy, they retrieved 2990 abstracts and analyzed 8 studies reporting caregiver burden estimates.
As has been reported in numerous other studies about unpaid caregiving, they were mostly female (57.9%-78.4%) and were caring for their spouse/partner (42.1%-45.3%). Most were in their early 60s.
Time spent caregiving ranged from 27-38 hours/week, according to 2 studies. Caregiving duration ranged from 3.7 to 5.0 years.
In one study, 69.1% of caregivers for those with CKD and anemia made at least 1 job-related decision due to caregiving, including retiring early, reducing work hours, or quitting their job.
Two studies reported depression was identified by 31.6% to 36.4% of caregivers, while 2 studies noted anxiety was present in 31.6% to 43.6%.
The researchers said the estimates of the impact on those caring for patients with CKD were sparse and heterogenous, but they pointed out the large amount of time spent caregiving and frequent identification of depression and anxiety among caregivers.
In both studies, the authors said more research is needed to fully understand these issues.
Both studies were funded by Boehringer Ingelheim Pharmaceuticals.
References
1. Osenenko KM, Chatterjee S, Ray S, Li T, Donato BM. Economic and humanistic burden among individuals with CKD in the United States: a systematic literature review. Presented at: Kidney Week 2022; November 3-6, 2022; Orlando, Florida. Abstract TH-PO726.
2. Osenenko KM, Chatterjee S, Ray S, Li T, Donato BM. Impact of caring for individuals with CKD in the United States: a systematic literature review. Presented at: Kidney Week 2022; November 3-6, 2022; Orlando, Florida. Abstract TH-PO893.
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More
Black Patients With Ulcerative Colitis Less Likely to Undergo IPAA Than White Patients
December 7th 2023Overall, the number of patients discharged from hospitals with an ulcerative colitis diagnosis increased between 2009 and 2018, but the number of patients opting for ileal pouch–anal anastomosis (IPAA) decreased.
Read More